• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

14.74 -0.18 (-1.19%)
Streaming Delayed Price Updated: 1:56 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,087
Open 14.91
Bid (Size) 14.76 (1)
Ask (Size) 15.30 (1)
Prev. Close 14.92
Today's Range 14.70 - 15.39
52wk Range 6.149 - 711.48
Shares Outstanding 833,683
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Completes Phase 1a Trial of TTX-MC138, Advancing to Phase 2 Evaluation
October 14, 2025
Via Investor Brand Network
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
October 08, 2025
Via AB Newswire
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-85.1%
-85.1%
1 Month
+26.3%
+26.3%
3 Month
+46.7%
+46.7%
6 Month
+93.2%
+93.2%
1 Year
-97.7%
-97.7%

More News

Read More
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Acquires Polynoma, Secures $25 Million Investment from CK Life Sciences to Advance Phase 2 Trial of TTX-MC138
October 08, 2025
Via Investor Brand Network
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout
October 08, 2025
Via Benzinga
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset
October 08, 2025
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 08, 2025
Via Benzinga
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
September 19, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 17, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 23, 2025
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
July 23, 2025
Via Chartmill
These stocks are gapping in today's session
July 23, 2025
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
July 23, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 23, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 21, 2025
Via Benzinga
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
May 28, 2025
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
May 28, 2025
Via Investor Brand Network
Which stocks are experiencing notable movement on Monday?
May 19, 2025
Via Chartmill
Top stock movements in today's session.
May 19, 2025
Via Chartmill
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
May 08, 2025
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Sets 1-for-28 Reverse Stock Split Effective May 15
May 06, 2025
Via Investor Brand Network
These stocks that are showing activity before the opening bell on Monday.
May 05, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 05, 2025
Via Benzinga
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
May 05, 2025
Via Benzinga
Topics Stocks World Trade
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
May 05, 2025
Via Benzinga
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday
May 05, 2025
Via Benzinga

Frequently Asked Questions

Is TransCode Therapeutics, Inc. - Common Stock publicly traded?
Yes, TransCode Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TransCode Therapeutics, Inc. - Common Stock trade on?
TransCode Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TransCode Therapeutics, Inc. - Common Stock?
The ticker symbol for TransCode Therapeutics, Inc. - Common Stock is RNAZ on the Nasdaq Stock Market
What is the current price of TransCode Therapeutics, Inc. - Common Stock?
The current price of TransCode Therapeutics, Inc. - Common Stock is 14.74
When was TransCode Therapeutics, Inc. - Common Stock last traded?
The last trade of TransCode Therapeutics, Inc. - Common Stock was at 10/17/25 01:56 PM ET
What is the market capitalization of TransCode Therapeutics, Inc. - Common Stock?
The market capitalization of TransCode Therapeutics, Inc. - Common Stock is 12.29M
How many shares of TransCode Therapeutics, Inc. - Common Stock are outstanding?
TransCode Therapeutics, Inc. - Common Stock has 12M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap